D. Margolis

First name
Middle name
Last name
Hennessy, S., Bilker, W. B., Knauss, J. S., Kimmel, S. E., Margolis, D. J., Morrison, M. F., et al. (2004). Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2004.02098.x
Gelfand, J. M., Shin, D. B., Neimann, A. L., Wang, X., Margolis, D. J., & Troxel, A. B. (2006). The risk of lymphoma in patients with psoriasis. J Invest Dermatol. http://doi.org/10.1038/sj.jid.5700410
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006). Risk of myocardial infarction in patients with psoriasis. Jama. http://doi.org/10.1001/jama.296.14.1735
Apter, A. J., Kinman, J. L., Bilker, W. B., Herlim, M., Margolis, D. J., Lautenbach, E., et al. (2006). Is there cross-reactivity between penicillins and cephalosporins?. Am J Med. http://doi.org/10.1016/j.amjmed.2005.10.052
Margolis, D. J., Bowe, W. P., Hoffstad, O., & Berlin, J. A. (2005). Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. http://doi.org/10.1001/archderm.141.9.1132
Bowe, W. P., Hoffstad, O., & Margolis, D. J. (2007). Upper respiratory tract infection in household contacts of acne patients. Dermatology. http://doi.org/10.1159/000106579
Margolis, D. J., Hoffstad, O., & Isseroff, R. R. (2007). Association between the use of beta-adrenergic receptor agents and the development of venous leg ulcers. Arch Dermatol. http://doi.org/10.1001/archderm.143.10.1275
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., et al. (2007). The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. http://doi.org/10.1001/archderm.143.12.1493
Lewis, J. D., Gelfand, J. M., Troxel, A. B., Forde, K. A., Newcomb, C., Kim, H., et al. (2008). Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol. http://doi.org/10.1111/j.1572-0241.2008.01836.x
Re, L., Carbonari, D. M., Saine, M. E., Newcomb, C. W., Roy, J. A., Liu, Q., et al. (2017). Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2017-000400